Ewa Otręba

Ewa Otręba

Auto-generated profile, based on publicly available information

Ewa Otręba

Medical University of Gdansk

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2023 in Medycyna Ogólna i Nauki o Zdrowiu
Verified
Journal Article
Open access
ZCZuzanna Chmielewska
Zuzanna Chmielewska
Krzysztof SobczakKrzysztof Sobczak
Krzysztof Sobczak
PDPaulina Dąbrowska
Paulina Dąbrowska
ADAnna Dąbrowska
Anna Dąbrowska
JŚJulia Świechowska
Julia Świechowska
MDMagdalena Dorobek
Magdalena Dorobek
Introduction and objective: The COVID-19 pandemic caused necessary changes to the health care system in terms of the organization and treatment of patients. Remote forms of medical consultations were widely introduced to minimize the risk of viral transmission. The aim of the study was to...

27 April 2025 in Archiv Euromedica
Verified
Journal Article
Closed access
MSMikołaj Szewczykowski
Mikołaj Szewczykowski
MDMagdalena Dorobek
Magdalena Dorobek
EOEwa Otręba
Ewa Otręba
TKTomasz Klinkosz
Tomasz Klinkosz
AWAleksander Walukiewicz
Aleksander Walukiewicz
FOFilip Ogończyk-Mąkowski
Filip Ogończyk-Mąkowski
Aims: Hypothyroidism is a disease that affects numerous people all over the world. The treatment is based on supplementation of thyroid hormones, however recent clinical trials, meta-analyses, and systematic reviews provide new insights about the role of micronutrients in this disease. Nevertheless, there are inconsistencies in the literature regarding the efficacy and necessity of supplementing these micronutrients in patients with hypothyroidism. The motivation to broach this topic was the dynamic growth of the dietary supplements market and the interest we observed among patients regarding the use of supplements in our clinical practice. Our goal is to evaluate the latest literature regarding the role of supplementation of iron, selenium, zinc and iodine in patients with hypothyroidism and its practical significance for healthcare professionals. Methods: The literature review was conducted using the PubMed and Google Scholar database. Publications from 2016–2024 were searched using specific keywords. Results: Hypothyroidism negatively affects iron metabolism, conversely iron deficiency impacts negatively the thyroid function. However, we have found only one prospective study showing benefits of iron supplementation in hypothyroidism patients. Selenium supplementation in hypothyroidism reduces TSH levels, this effect is intensified by co-supplementation of myo-inositol. No impact of selenium supplementation on T3 and T4 levels was described; also the impact on quality of life is controversial. There is still a lack of definitive evidence regarding the positive effects of zinc supplementation in hypothyroidism. Although both iodine deficiency and excessive iodine intake can lead to hypothyroidism, the impact of iodine supplementation specifically in patients with hypothyroidism remains unclear. Conclusions: The microelements have clinical impact on function, metabolism and conversion of thyroid hormones; however the effectiveness of supplementation in hypothyroidism has not been broadly examined.

30 June 2025 in Archiv Euromedica
Verified
Journal Article
Closed access
SKSzymon Korczyk
Szymon Korczyk
AKAleksandra Kaczmarek
Aleksandra Kaczmarek
MFMałgorzata Fudali
Małgorzata Fudali
MDMagdalena Dorobek
Magdalena Dorobek
EOEwa Otręba
Ewa Otręba
TKTomasz Klinkosz
Tomasz Klinkosz
Aims: The delay in childbearing and the associated decrease in fertility rates are the most notable trends in the majority of countries nowadays. This review aims to investigate oocyte cryopreservation (OC) as a fertility preservation technique and evaluate its significance in the context of delayed motherhood. Methods: The literature review was conducted using the PubMed and Google Scholar database. Approximately 40 articles that met the predetermined inclusion criteria were selected for analysis. Publications were published between 2009 and 2025, written in English, focusing on oocyte cryopreservation as a method of elective or medical fertility preservation. Results: Oocyte cryopreservation shows clinical outcomes comparable to fresh oocytes in IVF, better cost-effectiveness, and no increase in risk of congenital abnormalities. Live birth rates following OC range from 17.6% to 73%, with better results achieved in younger participants. The best outcomes were observed when oocytes were stored at 33 years of age and thawed at 43. Elective OC, compared to OC performed for medical reasons (e.g. oncological diseases) is associated with higher implantation rates. However, OC success rates and cost-effectiveness decline significantly with increasing age, with studies identifying 35 to 38 years as a critical threshold. While OC is generally safe, there remains a risk of complications such as ovarian hyperstimulation syndrome, and advanced maternal age is associated with an increased risk of obstetric complications. Conclusions: As women increasingly delay motherhood, OC offers an effective strategy to preserve fertility, particularly when performed before age 35. Success rates are strongly age-dependent, and early OC yields outcomes comparable to fresh IVF cycles without added congenital risk. Nevertheless, treatment costs and cycle numbers rise with maternal age, and success is not guaranteed. Broader education, accessibility, and personalized counseling are essential to optimize OC’s benefits and address gaps in knowledge regarding long-term outcomes.

28 February 2026 in Archiv Euromedica
Verified
Journal Article
Closed access
EOEwa OtręBa
Ewa OtręBa
JWJulia Wendt
Julia Wendt
MHMichał Hebel
Michał Hebel
SSSzymon Stankowski
Szymon Stankowski
MSMikołaj Szewczykowski
Mikołaj Szewczykowski
WFWiktor Fredrich
Wiktor Fredrich
Background Androgenetic alopecia is the most common form of progressive non scarring hair loss in men and is driven by dihydrotestosterone mediated miniaturization of hair follicles. The condition may negatively affect psychological well being and quality of life. Finasteride, a 5 alpha reductase inhibitor, is a key pharmacologic therapy. Aims To evaluate the mechanism of action, metabolism, efficacy, and safety of finasteride in male androgenetic alopecia, with comparison of oral and topical formulations, assessment of systemic exposure and DHT reduction, and review of adverse effects, alternative FDA approved treatments, combination strategies, and broader clinical relevance. Methods A narrative review was conducted using PubMed and Google Scholar for English language studies published between 2015 and 2026. Fifty one references were included. Priority was given to randomized controlled trials, systematic reviews, meta analyses, pharmacokinetic studies, and pharmacovigilance reports. Data were synthesized descriptively without formal quality assessment or meta analytic pooling. Results Finasteride inhibits type II and III 5 alpha reductase, lowering scalp and serum DHT levels and stabilizing hair growth. Oral finasteride 1 mg daily significantly improved hair count and density, with reported increases of 18.37 hairs per cm² in comparative analyses. Topical 0.25 percent formulations showed comparable efficacy after 24 weeks with markedly lower systemic exposure and smaller reductions in serum DHT. Oral therapy has been associated with sexual adverse effects and reported neuropsychiatric symptoms. Post finasteride syndrome remains controversial, and pharmacovigilance signals regarding depression and suicidal ideation require cautious interpretation. Combination regimens, particularly with topical minoxidil, demonstrated enhanced outcomes in selected studies. Finasteride is also approved for benign prostatic hyperplasia and has shown a reduction in overall prostate cancer incidence in long term trials. Conclusions Finasteride is a major therapeutic option for male androgenetic alopecia. Oral therapy provides robust efficacy but greater systemic exposure, whereas topical formulations offer similar hair growth outcomes with reduced systemic DHT suppression. Given the narrative design and heterogeneity of available data, conclusions should be interpreted with caution.

30 April 2026 in Archiv Euromedica
Verified
Journal Article
Closed access
TKTomasz Klinkosz
Tomasz Klinkosz
SSSzymon Stankowski
Szymon Stankowski
DFDagmara Fredrich
Dagmara Fredrich
WFWiktor Fredrich
Wiktor Fredrich
MSMikołaj Szewczykowski
Mikołaj Szewczykowski
SKSzymon Korczyk
Szymon Korczyk
Background Atrial fibrillation is one of the most common sustained cardiac arrhythmias and is associated with a high risk of ischemic stroke, thromboembolic complications, and mortality. Direct oral anticoagulants are widely used for stroke prevention in patients with atrial fibrillation and are currently considered standard therapy. However, the effectiveness of this therapy largely depends on long term patient adherence and persistence with treatment, since missed doses or premature discontinuation reduce the level of anticoagulant protection. Aims The aim of this review was to summarize current evidence on adherence and persistence to direct oral anticoagulant therapy in atrial fibrillation, to compare these indicators between individual agents, and to analyze factors influencing treatment adherence and associated clinical outcomes. Methods The study was conducted as a narrative literature review. Publications were searched in the PubMed and Google Scholar databases. Studies published between 2015 and 2025 were considered. Titles and abstracts were screened followed by full text assessment of potentially relevant studies. A total of 57 publications addressing treatment adherence, persistence, dosing practices, and clinical outcomes of direct oral anticoagulants in patients with atrial fibrillation were analyzed. Due to substantial heterogeneity of study designs and outcome measures, a qualitative synthesis of the evidence was performed without quantitative meta analysis. The comparative analysis focused on rivaroxaban, dabigatran, and apixaban. Edoxaban was not analyzed separately because of limited and heterogeneous data in the available studies. Results Analysis of published observational studies demonstrates substantial variability in adherence and treatment persistence among different direct oral anticoagulants. In most cohort studies higher adherence is observed with rivaroxaban and apixaban compared with dabigatran. Several studies also report longer treatment persistence with apixaban during long term follow up. These differences are partly explained by dosing regimens, treatment tolerability, and the frequency of adverse effects. Incorrect dosing of anticoagulants represents a common problem in clinical practice and is observed in a considerable proportion of patients, with underdosing occurring more frequently than overdosing. Deviations from recommended dosing regimens are associated with poorer clinical outcomes, including increased risk of thromboembolic complications. Treatment adherence is also influenced by multiple factors such as patient age, polypharmacy, complexity of dosing regimens, and socioeconomic conditions of medical care. Conclusions Adherence and persistence to direct oral anticoagulant therapy in patients with atrial fibrillation differ substantially between individual drugs and patient populations. Lower adherence is more frequently observed with dabigatran, whereas factor Xa inhibitors, particularly rivaroxaban and apixaban, demonstrate higher levels of treatment adherence in most studies. Incorrect dosing and clinical factors affecting treatment continuation represent important determinants of anticoagulant therapy effectiveness. Optimization of therapy requires individualized drug selection, appropriate dose adjustment according to renal function and clinical guidelines, and the implementation of strategies aimed at improving long term adherence to anticoagulant therapy.

1 January 2022 in Zdrowie Publiczne i Zarządzanie
Verified
Journal Article
Open access
PDF file
EOEwa Otręba
Ewa Otręba
MDMagdalena Dorobek
Magdalena Dorobek
ADAnna Dąbrowska
Anna Dąbrowska
Krzysztof SobczakKrzysztof Sobczak
Krzysztof Sobczak
JCJędrzej Czmyr
Jędrzej Czmyr
JŚJulia Świechowska
Julia Świechowska
During the COVID-19 pandemic, an increasing number of infections and a need for medical consultations forced the society to implement remote forms of contact with patients. The aim of this study was to analyze the experiences and preferences of patients regarding the doctor-patient relationship. A quantitative study was conducted using the CAWI technique. The study involved 1011 adult patients who were consulted by their family physicians. The patients generally declared unfavorable changes regarding their access to medical services. While comparing the experiences before and during the pandemic, most patients (70.3%) revealed that they had difficulties accessing their family physicians. Many patients (83.1%) preferred a personal visit as a form of consultation. Identification of the constraints relating to the COVID-19 pandemic can contribute to optimizing the health care system, particularly the organization of remote medical consultations.